11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Age-related effects of vagotonic atropine on cardiovagal baroreflex gain

      ,
      Neurobiology of Aging
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Impaired neural transduction of barosensory vessel stretch into vagal outflow is a primary determinant of reduced cardiovagal baroreflex gain with human aging. We set out to determine whether age-related reductions in this neural component of the baroreflex might be offset by enhancing the central integration/efferent responsiveness of the neural arc. Low vagotonic doses of atropine were employed to enhance central neural outflow and peripheral sinus node effects. Baroreflex gain and its neural and mechanical components were pharmacologically assessed before and after intravenous vagotonic atropine in 16 older and 14 young healthy subjects. Vagotonic atropine increased cardiovagal baroreflex gain (∼30%) and its neural component (∼20%) in older but not young individuals. Moreover, the atropine-induced increases in integrated gain and in its neural component were inversely related to baseline levels. Thus, age-related neural deficits in the baroreflex arc appear to play a determining role in reduced cardiovagal baroreflex gain with age and the compromised neural baroreflex function can be acutely improved by a single pharmacologic intervention. Copyright © 2012. Published by Elsevier Inc.

          Related collections

          Author and article information

          Journal
          Neurobiology of Aging
          Neurobiology of Aging
          Elsevier BV
          01974580
          February 2012
          February 2012
          : 33
          : 2
          : 368-374
          Article
          10.1016/j.neurobiolaging.2010.03.018
          20541842
          3ec09853-b7a2-481e-b02f-1e9900962f68
          © 2012

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article